Boussard & Gavaudan Investment Management LLP Catalent, Inc. Transaction History
Boussard & Gavaudan Investment Management LLP
- $167 Million
- Q2 2024
A detailed history of Boussard & Gavaudan Investment Management LLP transactions in Catalent, Inc. stock. As of the latest transaction made, Boussard & Gavaudan Investment Management LLP holds 382,836 shares of CTLT stock, worth $22.5 Million. This represents 12.87% of its overall portfolio holdings.
Number of Shares
382,836
Previous 9,918
3760.01%
Holding current value
$22.5 Million
Previous $559,000
3750.81%
% of portfolio
12.87%
Previous 0.18%
Shares
3 transactions
Others Institutions Holding CTLT
# of Institutions
484Shares Held
160MCall Options Held
364KPut Options Held
837K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$901 Million0.02% of portfolio
-
Nomura Holdings Inc Tokyo, M011MShares$645 Million1.22% of portfolio
-
State Street Corp Boston, MA7.34MShares$430 Million0.02% of portfolio
-
Barclays PLC London, X04.97MShares$291 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.6B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...